Agilent Technologies EBITDA 2010-2025 | A

Agilent Technologies annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Agilent Technologies EBITDA for the quarter ending April 30, 2025 was $373M, a 12.44% decline year-over-year.
  • Agilent Technologies EBITDA for the twelve months ending April 30, 2025 was $1.694B, a 9.57% increase year-over-year.
  • Agilent Technologies 2024 annual EBITDA was $1.745B, a 7.65% increase from 2023.
  • Agilent Technologies 2023 annual EBITDA was $1.621B, a 16.23% decline from 2022.
  • Agilent Technologies 2022 annual EBITDA was $1.935B, a 16.01% increase from 2021.
Agilent Technologies Annual EBITDA
(Millions of US $)
2024 $1,745
2023 $1,621
2022 $1,935
2021 $1,668
2020 $1,154
2019 $1,179
2018 $1,114
2017 $1,019
2016 $861
2015 $775
2014 $781
2013 $758
2012 $1,420
2011 $1,324
2010 $768
2009 $209
Agilent Technologies Quarterly EBITDA
(Millions of US $)
2025-04-30 $373
2025-01-31 $448
2024-10-31 $477
2024-07-31 $396
2024-04-30 $426
2024-01-31 $446
2023-10-31 $470
2023-07-31 $204
2023-04-30 $454
2023-01-31 $493
2022-10-31 $544
2022-07-31 $491
2022-04-30 $442
2022-01-31 $458
2021-10-31 $479
2021-07-31 $420
2021-04-30 $365
2021-01-31 $404
2020-10-31 $375
2020-07-31 $307
2020-04-30 $178
2020-01-31 $294
2019-10-31 $326
2019-07-31 $280
2019-04-30 $269
2019-01-31 $304
2018-10-31 $300
2018-07-31 $274
2018-04-30 $260
2018-01-31 $280
2017-10-31 $251
2017-07-31 $252
2017-04-30 $255
2017-01-31 $261
2016-10-31 $239
2016-07-31 $206
2016-04-30 $195
2016-01-31 $221
2015-10-31 $216
2015-07-31 $206
2015-04-30 $170
2015-01-31 $183
2014-10-31 $253
2014-07-31 $221
2014-04-30 $191
2014-01-31 $220
2013-10-31 $380
2013-07-31 $327
2013-04-30 $305
2013-01-31 $311
2012-10-31 $372
2012-07-31 $354
2012-04-30 $361
2012-01-31 $333
2011-10-31 $376
2011-07-31 $344
2011-04-30 $330
2011-01-31 $274
2010-10-31 $270
2010-07-31 $175
2010-04-30 $190
2010-01-31 $133
2009-10-31 $111
2009-07-31 $40
2009-04-30 $-7
2009-01-31 $65
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $34.275B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.329B 28.06
Boston Scientific (BSX) United States $153.315B 38.38
Stryker (SYK) United States $149.550B 31.27
EssilorLuxottica (ESLOY) France $129.320B 0.00
Medtronic (MDT) Ireland $113.223B 16.05
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $46.111B 26.31
ResMed (RMD) United States $37.519B 28.18
GE HealthCare Technologies (GEHC) United States $34.854B 16.55
Terumo (TRUMY) Japan $25.791B 33.50
Koninklijke Philips (PHG) Netherlands $23.611B 16.57
Insulet (PODD) United States $21.226B 83.32
Zimmer Biomet Holdings (ZBH) United States $18.499B 11.88
Baxter (BAX) United States $15.975B 11.93
Smith & Nephew SNATS (SNN) United Kingdom $13.209B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.821B 23.74
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $3.962B 17.70
Perrigo (PRGO) Ireland $3.748B 9.50
Haemonetics (HAE) United States $3.663B 16.68
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.419B 28.41
ICU Medical (ICUI) United States $3.352B 24.72
QuidelOrtho (QDEL) United States $2.041B 14.04
LeMaitre Vascular (LMAT) United States $1.894B 42.35
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.375B 0.00
AdaptHealth (AHCO) United States $1.264B 12.84
Green Thumb Industries (GTBIF) United States $1.169B 26.29
Neogen (NEOG) United States $1.135B 14.53
Phibro Animal Health (PAHC) United States $1.133B 14.48
BioLife Solutions (BLFS) United States $1.081B 0.00
InMode (INMD) Israel $0.961B 9.69
Kestra Medical Technologies (KMTS) United States $0.783B 0.00
Owens & Minor (OMI) United States $0.718B 5.96
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
CeriBell (CBLL) United States $0.673B 0.00
Evolus (EOLS) United States $0.594B 0.00
Curaleaf Holdings (CURLF) Canada $0.551B 0.00
Valneva SE (VALN) France $0.494B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Capricor Therapeutics (CAPR) United States $0.458B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
Quanterix (QTRX) United States $0.346B 0.00
SNDL (SNDL) Canada $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Cerus (CERS) United States $0.298B 0.00
Viemed Healthcare (VMD) United States $0.280B 23.60
ZimVie (ZIMV) United States $0.279B 12.67
Sanuwave Health (SNWV) United States $0.271B 0.00
Sanara MedTech (SMTI) United States $0.266B 0.00
Aurora Cannabis (ACB) Canada $0.251B 74.50
Cresco Labs (CRLBF) United States $0.251B 0.00
Brainsway (BWAY) Israel $0.242B 64.00
Biote (BTMD) United States $0.229B 6.45
OraSure Technologies (OSUR) United States $0.229B 0.00
Canopy Growth (CGC) Canada $0.219B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.21
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
Verano Holdings (VRNOF) United States $0.182B 0.00
Omeros (OMER) United States $0.181B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.128B 15.73
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.096B 12.33
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MacroGenics (MGNX) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Agape ATP (ATPC) $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Nephros (NEPH) United States $0.042B 56.86
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.81
Safety Shot (SHOT) United States $0.030B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00